541 related articles for article (PubMed ID: 14974329)
1. [First comparison of 2 statins shows: only radical LDL lowering stops coronary atherosclerosis].
Einecke D
MMW Fortschr Med; 2003 Dec; 145(51-52):38. PubMed ID: 14974329
[No Abstract] [Full Text] [Related]
2. [High lowering of lipids can melt coronary plaques -- is coronary disease reversible?].
Einecke D
MMW Fortschr Med; 2006 Jun; 148(24):4-5. PubMed ID: 16850796
[No Abstract] [Full Text] [Related]
3. [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly].
MMW Fortschr Med; 2005 Aug; 147(33-34):50-1. PubMed ID: 16138640
[No Abstract] [Full Text] [Related]
4. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.
Nissen SE; Tuzcu EM; Schoenhagen P; Crowe T; Sasiela WJ; Tsai J; Orazem J; Magorien RD; O'Shaughnessy C; Ganz P;
N Engl J Med; 2005 Jan; 352(1):29-38. PubMed ID: 15635110
[TBL] [Abstract][Full Text] [Related]
5. [How can lipid therapy be improved? Cardiologists insist on dual cholesterol inhibition].
MMW Fortschr Med; 2005 Nov; 147(45):54. PubMed ID: 16320655
[No Abstract] [Full Text] [Related]
6. [For coronary disease patients is certain: the lower the LDL the better].
MMW Fortschr Med; 2006 Jun; 148(24):6. PubMed ID: 16850797
[No Abstract] [Full Text] [Related]
7. High-intensity statin treatment for coronary heart disease.
Sacks FM
JAMA; 2004 Mar; 291(9):1132-4. PubMed ID: 14996784
[No Abstract] [Full Text] [Related]
8. [Results of randomized study: intensive lipid lowering treatment stops coronary atherosclerosis].
MMW Fortschr Med; 2004 Mar; 146(13):64-5. PubMed ID: 15219142
[No Abstract] [Full Text] [Related]
9. Cholesterol limbo: How low should the bar go. Ratcheting down LDL to extra-low levels with high-dose statins seems to work wonders.
Harv Health Lett; 2004 May; 29(7):1-2. PubMed ID: 15153394
[No Abstract] [Full Text] [Related]
10. C-reactive protein levels and outcomes after statin therapy.
Clearfield M
Curr Atheroscler Rep; 2006 Jan; 8(1):8-9. PubMed ID: 16455006
[No Abstract] [Full Text] [Related]
11. [Coronary disease prevention: only the inhibition of inflammation is important. Why lower lipids, too?].
Sudhop T; von Bergmann K
MMW Fortschr Med; 2003 May; 145(21):19. PubMed ID: 12845862
[No Abstract] [Full Text] [Related]
12. [Lowering of cholesterol. What role is played by the choice of statins?].
März W
MMW Fortschr Med; 2004 Sep; 146(35-36):55. PubMed ID: 15540544
[No Abstract] [Full Text] [Related]
13. [LDL cholesterol in normal range. The lower the better? Implications of the GREACE study].
März W
MMW Fortschr Med; 2003 Dec; 145(50):46-9. PubMed ID: 14963971
[TBL] [Abstract][Full Text] [Related]
14. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
Nissen SE; Tuzcu EM; Schoenhagen P; Brown BG; Ganz P; Vogel RA; Crowe T; Howard G; Cooper CJ; Brodie B; Grines CL; DeMaria AN;
JAMA; 2004 Mar; 291(9):1071-80. PubMed ID: 14996776
[TBL] [Abstract][Full Text] [Related]
15. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
van der Harst P; Voors AA; van Veldhuisen DJ
N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15306676
[No Abstract] [Full Text] [Related]
16. Comparison of statins in hypertriglyceridemia.
Stein EA; Lane M; Laskarzewski P
Am J Cardiol; 1998 Feb; 81(4A):66B-69B. PubMed ID: 9526817
[TBL] [Abstract][Full Text] [Related]
17. [CARDS confirms usefulness of LDL lowering in type 2 diabetics].
Bern VH
Praxis (Bern 1994); 2004 Oct; 93(44):1 p following 1830. PubMed ID: 15559908
[No Abstract] [Full Text] [Related]
18. Effect of atorvastatin (80 mg/day) versus pravastatin (40 mg/day) on arterial remodeling at coronary branch points (from the REVERSAL study).
Nicholls SJ; Tuzcu EM; Schoenhagen P; Sipahi I; Crowe T; Kapadia S; Nissen SE
Am J Cardiol; 2005 Dec; 96(12):1636-9. PubMed ID: 16360349
[TBL] [Abstract][Full Text] [Related]
19. Aggressive low-density lipoprotein cholesterol lowering in secondary prevention of coronary heart disease.
Clearfield M
Curr Atheroscler Rep; 2006 Jan; 8(1):7-8. PubMed ID: 16455005
[No Abstract] [Full Text] [Related]
20. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
Gotto AM
N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309745
[No Abstract] [Full Text] [Related]
[Next] [New Search]
